KATHERINE MCDUFFIE: Open Payments
NPI 1114252160 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 13 payments from 6 companies in 2025. Trend: 2023 $214 · 2024 $261 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 6 | $120 |
| Amgen Inc. | 2 | $28 |
| BridgeBio Pharma, Inc. | 2 | $28 |
| Boston Scientific Corporation | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: AMVUTTRA, REPATHA, Attruby, WATCHMAN FLX, LEQVIO, CAMZYOS.
Industry payments across MS — which companies pay providers there.
